FDA Import Refusal 1FX-0822878-6/20002/1 — Cipla Limited

Cipla Limited — FEI 3007021905

The FDA refused shipment 1FX-0822878-6/20002/1 from Cipla Limited (India) on Sep 19, 2026. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.